Aisling Kelly

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Squamous Cell Carcinoma

Infectious Diseases

Top Venues

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Dheeraj Soni, Francesco Borriello, David A Scott, Frederic Feru, Maria De Leon, Spencer E Brightman, Wing Ki Cheng, Gandolina Melhem, Jennifer A Smith, Juan C Ramirez, Soumik Barman, Michael D Cameron, Aisling Kelly, Kristina Walker, Etsuro Nanishi, Simon Daniel van Haren, Tony Phan, Yizhi Qi, Robert Kinsey, Michal M Rączy, Al Ozonoff, Matthew A Pettengill, Jeffrey A Hubbell, Christopher B Fox, David J Dowling, Ofer Levy
From hit to vial: Precision discovery and development of an imidazopyrimidine TLR7/8 agonist adjuvant formulation. Science advances 10 (27) (2024)
Dheeraj Soni, Francesco Borriello, David A Scott, Frederic Feru, Maria De Leon, Spencer E Brightman, Wing Ki Cheng, Gandolina Melhem, Jennifer A Smith, Juan C Ramirez, Soumik Barman, Michael D Cameron, Aisling Kelly, Kristina Walker, Etsuro Nanishi, Simon Daniel van Haren, Tony Phan, Yizhi Qi, Robert Kinsey, Michal M Rączy, Al Ozonoff, Matthew A Pettengill, Jeffrey A Hubbell, Christopher B Fox, David J Dowling, Ofer Levy
From hit to vial: Precision discovery and development of an imidazopyrimidine TLR7/8 agonist adjuvant formulation. Science advances 10 (27) (2024)
Dheeraj Soni, Francesco Borriello, David A Scott, Frederic Feru, Maria De Leon, Spencer E Brightman, Wing Ki Cheng, Gandolina Melhem, Jennifer A Smith, Juan C Ramirez, Soumik Barman, Michael D Cameron, Aisling Kelly, Kristina Walker, Etsuro Nanishi, Simon Daniel van Haren, Tony Phan, Yizhi Qi, Robert Kinsey, Michal M Rączy, Al Ozonoff, Matthew A Pettengill, Jeffrey A Hubbell, Christopher B Fox, David J Dowling, Ofer Levy
From hit to vial: Precision discovery and development of an imidazopyrimidine TLR7/8 agonist adjuvant formulation. Science advances 10 (27) (2024)